Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00949923 · ClinicalTrials.gov registry record · NA
Green Tea in Breast Cancer Patients
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT00949923 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 41 participants.
The verdict
NCT00949923, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
Prognostic factors for breast cancer beyond stage at diagnosis and tumor characteristics have not been well studied. Of special interest are lifestyle factors that can be modified by women after diagnosis to increase disease-free survival. Green tea is rich in polyphenols consisting primarily of epicatechins, epigallocatechin, epicatechin gallate, and epigallocatechin gallate (EGCG). The investigators hypothesize that there will be a reduction in proliferation and/or an increase in apoptosis in association with short-term EGCG treatment.
Interventions
- DIETARY_SUPPLEMENT tea capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2008-05-07 |
| Est. Completion | 2016-06-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00949923
The ClinicalTrials.gov registry entry for NCT00949923 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which tea capsule is the first listed.
NCT00949923 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00949923 about?
NCT00949923 is a clinical study titled "Green Tea in Breast Cancer Patients". Prognostic factors for breast cancer beyond stage at diagnosis and tumor characteristics have not been well studied. Of special interest are lifestyle factors that can be modified by women after diagnosis to increase disease-free survival. Green tea is rich in polyphenols consisting primarily of epi...
What is the current status of trial NCT00949923?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2008-05-07. Estimated completion is 2016-06-06.
What interventions are being tested in trial NCT00949923?
The interventions under investigation include: tea capsule (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00949923?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.